BACKGROUND: Open radical cystectomy (ORC) with pelvic lymph-node dissection (PLND) for bladder cancer (BCa) and urinary diversion is a morbid procedure, and advanced age has been associated with a higher incidence of Clavien-Dindo ≥ 3 complications. AIM: To investigate the association between chronological age, survival outcomes, incidence of perioperative complications, and quality parameters in patients undergoing ORC. METHODS: We reviewed 413 patients who underwent ORC and PLND at a single academic centre between December 2009 and June 2018 for cT2-T4N0M0 BCa. Complete clinical, demographic, and pathological data were collected in the preoperative, preoperative, and postoperative setting. Patients were categorized as ≥ 75 years or < 75 years and statistical analysis was performed accordingly. Besides descriptive statistics, Kaplan-Meier log-rank test was used. Cox regression univariate and multivariate analyses were used to assess any potential predictor of OS and CSS. RESULTS: There were 285 (69%) patients < 75 years and 128 (31%) patients ≥ 75 years old. There was no significant difference between the two age groups neither in terms of distribution of pathological stage nor in terms of overall incidence of postoperative complications. Chronological age was not significantly associated with survival outcomes on multivariate analysis. Finally, the comorbidity index was the only significant risk factor for the incidence of any complications (OR = 0.83, p = 0.002) at multivariate binary logistic regression. CONCLUSION: Open radical cystectomy (ORC) is a feasible and safe procedure in patients with high-risk non-metastatic bladder cancer. Uro-oncologists should consider evaluating elderly patients for surgery according to a thorough geriatric assessment despite chronological age.
BACKGROUND: Open radical cystectomy (ORC) with pelvic lymph-node dissection (PLND) for bladder cancer (BCa) and urinary diversion is a morbid procedure, and advanced age has been associated with a higher incidence of Clavien-Dindo ≥ 3 complications. AIM: To investigate the association between chronological age, survival outcomes, incidence of perioperative complications, and quality parameters in patients undergoing ORC. METHODS: We reviewed 413 patients who underwent ORC and PLND at a single academic centre between December 2009 and June 2018 for cT2-T4N0M0 BCa. Complete clinical, demographic, and pathological data were collected in the preoperative, preoperative, and postoperative setting. Patients were categorized as ≥ 75 years or < 75 years and statistical analysis was performed accordingly. Besides descriptive statistics, Kaplan-Meier log-rank test was used. Cox regression univariate and multivariate analyses were used to assess any potential predictor of OS and CSS. RESULTS: There were 285 (69%) patients < 75 years and 128 (31%) patients ≥ 75 years old. There was no significant difference between the two age groups neither in terms of distribution of pathological stage nor in terms of overall incidence of postoperative complications. Chronological age was not significantly associated with survival outcomes on multivariate analysis. Finally, the comorbidity index was the only significant risk factor for the incidence of any complications (OR = 0.83, p = 0.002) at multivariate binary logistic regression. CONCLUSION: Open radical cystectomy (ORC) is a feasible and safe procedure in patients with high-risk non-metastatic bladder cancer. Uro-oncologists should consider evaluating elderly patients for surgery according to a thorough geriatric assessment despite chronological age.
Authors: Philipp Gild; David-Dan Nguyen; Sean A Fletcher; Alexander P Cole; Stuart R Lipsitz; Adam S Kibel; Margit Fisch; Mark A Preston; Quoc-Dien Trinh Journal: Clin Genitourin Cancer Date: 2019-01-29 Impact factor: 2.872
Authors: L Decoster; K Van Puyvelde; S Mohile; U Wedding; U Basso; G Colloca; S Rostoft; J Overcash; H Wildiers; C Steer; G Kimmick; R Kanesvaran; A Luciani; C Terret; A Hurria; C Kenis; R Audisio; M Extermann Journal: Ann Oncol Date: 2014-06-16 Impact factor: 32.976
Authors: Mohamed E Ahmed; Giovanni Motterle; Jack R Andrews; Marco Moschini; Eugene D Kwon; Robert J Karnes Journal: Clin Genitourin Cancer Date: 2019-10-16 Impact factor: 2.872
Authors: Giorgio Gandaglia; Nicola Fossati; R Jeffrey Karnes; Stephen A Boorjian; Michele Colicchia; Alberto Bossi; Thomas Seisen; Cesare Cozzarini; Nadia Di Muzio; Barbara Noris Chiorda; Emanuele Zaffuto; Thomas Wiegel; Shahrokh F Shariat; Gregor Goldner; Steven Joniau; Antonino Battaglia; Karin Haustermans; Gert De Meerleer; Valérie Fonteyne; Piet Ost; Hendrick Van Poppel; Francesco Montorsi; Alberto Briganti Journal: Eur Urol Date: 2017-12-08 Impact factor: 20.096
Authors: Xuezheng Sun; Katherine A Hoadley; William Y Kim; Helena Furberg; Andrew F Olshan; Melissa A Troester Journal: Cancer Causes Control Date: 2017-03-20 Impact factor: 2.506
Authors: Xiaosong Meng; Benjamin Press; Audrey Renson; James S Wysock; Samir S Taneja; William C Huang; Marc A Bjurlin Journal: Clin Genitourin Cancer Date: 2018-02-26 Impact factor: 2.872
Authors: Łukasz Zapała; Aleksander Ślusarczyk; Bartłomiej Korczak; Paweł Kurzyna; Mikołaj Leki; Piotr Lipiński; Jerzy Miłow; Michał Niemczyk; Kamil Pocheć; Michał Późniak; Maciej Przudzik; Tomasz Suchojad; Rafał Wolański; Piotr Zapała; Tomasz Drewa; Marek Roslan; Waldemar Różański; Andrzej Wróbel; Piotr Radziszewski Journal: Front Oncol Date: 2022-01-26 Impact factor: 6.244